<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2184-0628</journal-id>
<journal-title><![CDATA[Gazeta Médica]]></journal-title>
<abbrev-journal-title><![CDATA[Gaz Med]]></abbrev-journal-title>
<issn>2184-0628</issn>
<publisher>
<publisher-name><![CDATA[Círculo Médico]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2184-06282020000300277</article-id>
<article-id pub-id-type="doi">10.29315/gm.v7i3.300</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Neoplasia Folicular da Tiroide Não Invasiva com Aspetos Nucleares de Carcinoma Papilífero]]></article-title>
<article-title xml:lang="en"><![CDATA[Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Features]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Correia]]></surname>
<given-names><![CDATA[Paulo Costa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Coutinho]]></surname>
<given-names><![CDATA[Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A3"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caldes]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,ULS Guarda  ]]></institution>
<addr-line><![CDATA[Guarda ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade da Beira Interior (UBI) Faculdade de Medicina ]]></institution>
<addr-line><![CDATA[Covilhã ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,ULS Guarda  ]]></institution>
<addr-line><![CDATA[Guarda ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>09</month>
<year>2020</year>
</pub-date>
<volume>7</volume>
<numero>3</numero>
<fpage>277</fpage>
<lpage>281</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2184-06282020000300277&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2184-06282020000300277&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2184-06282020000300277&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo A neoplasia folicular da tiroide não invasiva com aspetos nucleares de carcinoma papilar (NIFTP) é uma neoplasia encapsulada com padrão de crescimento folicular e características nucleares do carcinoma papilar da tiroide. Eram conhecidos como &#8220;variante folicular não-invasiva e encapsulada do carcinoma papilar da tiroide, mas dada a sua semelhança biológica aos adenomas foliculares (comportamento indolente e ausência de metástases linfáticas ou recorrência), a nomenclatura foi alterada. Em 2015 um painel de especialistas decidiu chamar-lhe NIFTP. Apesar da elevada suspeição, o diagnóstico definitivo apenas é possível através do estudo histológico da peça cirúrgica. Uma vez feito o diagnóstico, não sendo uma lesão maligna, não é necessário submeter os doentes a estadiamento nem protocolos de tratamento oncológico. Apresentam-se dois casos clínicos em que se procedeu a tiroidectomia total em contexto multinodular. A NIFTP é muitas vezes tratada excessiva/agressivamente, o que acarreta morbilidade e stress psicológico para os doentes, bem como custos desnecessários aos sistemas de saúde.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Noninvasive thyroid follicular neoplasia with nuclear aspects of papillary carcinoma (NIFTP) is an encapsulated neoplasm with follicular growth pattern and nuclear features of papillary thyroid carcinoma. They were known as &#8220;noninvasive and encapsulated follicular variant of papillary thyroid carcinoma, but given their biological similarity to follicular adenomas (indolent behavior and absence of lymphatic metastases or recurrence), the nomenclature was altered. In 2015 a panel of experts decided to call it NIFTP. Despite the high suspicion, the definitive diagnosis is only possible through the histological study of the surgical specimen. Once the diagnosis is made, not being a malignant lesion, it is not necessary to subject patients to staging or cancer treatment protocols. Two clinical cases were presented in which total thyroidectomy was performed in a multinodular context. NIFTP is often overtreated/aggressively which causes morbidity and stress.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Adenocarcinoma Folicular]]></kwd>
<kwd lng="pt"><![CDATA[Carcinoma Papilífero da Tiroide]]></kwd>
<kwd lng="pt"><![CDATA[Neoplasias da Tiroide]]></kwd>
<kwd lng="en"><![CDATA[Adenocarcinoma, Follicular]]></kwd>
<kwd lng="en"><![CDATA[Carcinoma, Papillary]]></kwd>
<kwd lng="en"><![CDATA[Thyroid Neoplasms]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Filetti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Durante]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hartl]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Leboulleux]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Locati]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Newbold]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up]]></article-title>
<source><![CDATA[Ann Oncol]]></source>
<year>2019</year>
<volume>30</volume>
<page-range>1856-83</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Howe]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
<name>
<surname><![CDATA[Ries]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Thun]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Yancik]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Wingo]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2002</year>
<volume>94</volume>
<page-range>2766-92</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Golbert]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wajner]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Maia]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Gross]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carcinoma diferenciado da tiroide. Avaliação Inicial e Acompanhamento]]></article-title>
<source><![CDATA[Arq Bras Endocrinol Metab]]></source>
<year>2005</year>
<volume>49</volume>
<page-range>701-10</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Grort]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Larsen]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Hennemain]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[The Thyroid and its diseases]]></source>
<year>1996</year>
<edition>6th ed</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Churchill Livingstone]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cibas]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[SZ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 2017 Bethesda System for Reporting Thyroid Cytopathology]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2017</year>
<volume>27</volume>
<page-range>1341-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shattuck]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Westra]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Ladenson]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2005</year>
<volume>352</volume>
<page-range>2406-12</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosario]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Mourão]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Follow-up of noninvasive folicular thyroid neoplasm with papillary-like nuclear features (NIFTP)]]></article-title>
<source><![CDATA[Head Neck]]></source>
<year>2019</year>
<volume>41</volume>
<page-range>833-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nikiforov]]></surname>
<given-names><![CDATA[YE]]></given-names>
</name>
<name>
<surname><![CDATA[Seethala]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Tallini]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Baloch]]></surname>
<given-names><![CDATA[ZW]]></given-names>
</name>
<name>
<surname><![CDATA[Basolo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors]]></article-title>
<source><![CDATA[JAMA Oncol]]></source>
<year>2016</year>
<volume>2</volume>
<page-range>1023-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
